This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poulain-Godefroy, O.
Right arrow Articles by Riveau, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poulain-Godefroy, O.
Right arrow Articles by Riveau, G.

 Previous Article  |  Next Article 

Infect Immun, April 1998, p. 1764-1767, Vol. 66, No. 4
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Bordetella pertussis Filamentous Hemagglutinin Enhances the Immunogenicity of Liposome-Delivered Antigen Administered Intranasally

Odile Poulain-Godefroy,1,* Nathalie Mielcarek,1,dagger Nathalie Ivanoff,1,Dagger Franck Remoué,1 Anne-Marie Schacht,1 Nigel Phillips,2 Camille Locht,3 André Capron,1 and Gilles Riveau1

INSERM U1671 and INSERM U477,3 Institut Pasteur de Lille, F-59019 Lille Cedex, France, and Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada2

Received 5 September 1997/Returned for modification 24 November 1997/Accepted 20 January 1998

In an attempt to increase the immunogenicity of mucosally delivered antigens, we incorporated the Bordetella pertussis filamentous hemagglutinin (FHA) adhesin into liposomes containing the glutathione S-transferase of Schistosoma mansoni (Sm28GST) as a model antigen. Outbred mice immunized twice intranasally with liposomes containing a constant suboptimal dose of Sm28GST and increasing doses of FHA produced anti-Sm28GST antibodies in a FHA dose-dependent manner. The addition of 3 µg of FHA to the liposomes induced more than 10-fold-higher anti-Sm28GST antibody titers, compared to those induced by liposomes without FHA. The presence of FHA did not alter the nature of the humoral immune response, and the sera contained anti-Sm28GST immunoglobulin G1 (IgG1), IgG2a, and IgG2b. However, anti-Sm28GST IgA was only detected when at least 3 µg of FHA was added to the preparation. These results show a promising potential for FHA to enhance the immunogenicity of mucosally administered antigens incorporated into liposomes.


* Corresponding author. Mailing address: INSERM U167, Institut Pasteur de Lille, 1, rue du Professeur Calmette, BP 245, F-59019 Lille Cedex, France. Phone: (33) 3 20 87 77 81. Fax: (33) 3 20 87 78 88. E-mail: odile.poulain{at}pasteur-lille.fr.

dagger Present address: University of Göteborg, Dept. Medical Microbiology, 41346 Göteborg, Sweden.

Dagger Present address: Merck Sharp & Dohme Research Laboratories, 69367 Lyon Cedex 07, France.




This article has been cited by other articles:

  • Ross, A. G. P., Sleigh, A. C., Li, Y., Davis, G. M., Williams, G. M., Jiang, Z., Feng, Z., McManus, D. P. (2001). Schistosomiasis in the People's Republic of China: Prospects and Challenges for the 21st Century. Clin. Microbiol. Rev. 14: 270-295 [Abstract] [Full Text]